Journal article
Acceptability and feasibility of oral swabs for tuberculosis diagnosis in young children: a qualitative study from Uganda and Peru
- Abstract:
- Background: Tuberculosis (TB) remains a leading cause of morbidity and mortality in young children, particularly in settings with limited diagnostic capacity. Oral swabs represent a promising alternative specimen type due to their ease of collection, but evidence regarding their acceptability and feasibility remains limited. Methods: This qualitative sub-study was nested within the NOD-pedFEND diagnostic trial evaluating novel tests for pediatric TB. We conducted semi-structured interviews and focus group discussions with 81 participants across Uganda (n = 57) and Peru (n = 24), including caregivers (Uganda, n = 30; Peru, n = 7), healthcare workers (Uganda, n = 23; Peru, n = 12), and National TB Program stakeholders (Uganda, n = 4; Peru, n = 5). Participants were recruited purposively from among those involved in or linked to the parent NOD-pedFEND study. Data were analyzed using thematic analysis. Results: Oral swabs were widely perceived as acceptable due to their non-invasive nature, minimal discomfort, and ease of collection. Caregivers and healthcare workers valued the reduced burden on children compared to more invasive sampling methods. Across both countries, participants expressed concerns about perceived low diagnostic sensitivity in children, particularly when compared with reference standard specimens. Despite these reservations, oral swabs were welcomed as a complementary, rather than substitute, diagnostic modality. Stakeholders highlighted their potential role within future point-of-care diagnostic strategies in low-resource settings. Conclusions: Oral swabs are acceptable and feasible for pediatric TB diagnosis in diverse settings, though concerns about sensitivity persist. Their integration as an add-on test could expand diagnostic access, especially if incorporated into scalable, point-of-care approaches.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 673.5KB, Terms of use)
-
- Publisher copy:
- 10.3389/ftubr.2026.1726647
Authors
+ National Institute of Allergy and Infectious Diseases
More from this funder
- Funder identifier:
- https://ror.org/043z4tv69
- Grant:
- U01AI152084
+ European Society for Paediatric Infectious Diseases
More from this funder
- Funder identifier:
- https://ror.org/00jvfh371
- Publisher:
- Frontiers Media
- Journal:
- Frontiers in Tuberculosis More from this journal
- Volume:
- 4
- Pages:
- 1726647
- Article number:
- 1726647
- Publication date:
- 2026-02-12
- Acceptance date:
- 2026-01-22
- DOI:
- EISSN:
-
2813-7868
- ISSN:
-
2813-7868
- Language:
-
English
- Keywords:
- Pubs id:
-
2380208
- Local pid:
-
pubs:2380208
- Source identifiers:
-
3801891
- Deposit date:
-
2026-02-26
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record